alaproclate has been researched along with Coronary Artery Disease in 1 studies
alaproclate: specific 5-hydroxytryptamine uptake inhibitors; RN given refers to (DL)-isomer
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vilahur, G | 1 |
| Casani, L | 1 |
| Mendieta, G | 1 |
| Lamuela-Raventos, RM | 1 |
| Estruch, R | 1 |
| Badimon, L | 1 |
1 other study available for alaproclate and Coronary Artery Disease
| Article | Year |
|---|---|
Beer elicits vasculoprotective effects through Akt/eNOS activation.
Topics: Acetylcholine; Alanine; Animals; Beer; Cholesterol; Coronary Artery Disease; Coronary Vessels; Diet, | 2014 |